What Macter does

Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi and traded on the Pakistan Stock Exchange under the ticker MACTER. The company produces pharmaceutical, biological, and consumer health products across antibiotics, anti-diabetics, anti-ulcerants, anti-virals, anti-epileptics, oncology, nephrology, vaccines, probiotics, vitamins, supplements, and over-the-counter medications, organized across three product categories — Pharmaceutical, Biological, and Consumer. Operationally, Macter runs a manufacturing capacity of approximately 1 billion tablets per year with state-of-the-art biotech and sterile facilities, ISO-aligned Quality Management, Environmental, and Occupational Health & Safety Management Systems, and a microbiology laboratory supporting sterility, microbial limit, bacterial endotoxin, and water testing. The business model combines contract manufacturing for world-leading multinational healthcare companies — where Macter is positioned as the largest such contract manufacturer in Pakistan — with branded sales of its own portfolio across a domestic distribution network and exports to 16 countries. Commercial reach is sustained by a 400+ field force running Continuous Medical Education programs, ward presentations, local speaker programs, and KOL focus groups across diabetes, cardiology, pulmonology, virology, hepatology, and orthopedics, supplemented by corporate social responsibility programs including Hepatitis B vaccination partnerships.

Name

Macter

Legal name

Macter International Limited

Website

https://macter.com

Company type

Public

Founded year

1980

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Macter International Limited is a publicly listed Pakistani pharmaceutical manufacturer headquartered in Karachi that produces branded pharmaceutical, biological, and consumer health products and operates as the largest contract manufacturer for world-leading healthcare companies in Pakistan, exporting to 16 countries with capacity of 1 billion tablets per year.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing
• Biological products
• Consumer health products
• Generic medicines

Headquarters

HQ city

Karachi

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Contract Manufacturing: Manufacturing pharmaceutical products for world leading healthcare companies as the largest contract manufacturer in Pakistan
2. Pharmaceutical Products Sales: Sale of branded pharmaceutical products including antibiotics, anti-diabetics, cardiovascular drugs, and anti-cancer medications
3. Biological Products Sales: Sale of biological products including vaccines, probiotics, and biotech medications
4. Consumer Products Sales: Sale of consumer health products including vitamins, supplements, and over-the-counter medications

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Macter International Limited manufactures and markets pharmaceutical, biological, and consumer health products, and operates as the largest contract manufacturer in Pakistan for world-leading healthcare companies. The company produces over 1 billion tablets annually across therapeutic categories including antibiotics, anti-diabetics, cardiovascular, anti-cancer, anti-virals, anti-epileptics, and biologics such as GLP-1 receptor agonists and anti-TNF agents, exporting to 16 countries.

Product overview

Macter International Limited is a Pakistani pharmaceutical company serving as a contract manufacturer for world-leading healthcare companies. The company operates with three main product categories: Pharmaceutical Products (antibiotics, anti-diabetics, anti-ulcerants, anti-virals, anti-epileptics, and specialty medicines in tablet, capsule, syrup, injection, and infusion forms), Biological Products (GLP-1 receptor agonists like TirzaTrim and Seglu, anti-TNF agents like Fliximac, and other biologic therapies), and Consumer Products (vitamin D supplements like DX3 and calcium supplements like Avelia). With manufacturing capacity exceeding 1 billion tablets annually and presence across 16 countries, Macter offers both contract manufacturing services and branded pharmaceutical products through its distribution network.

Differentiator

Problem solved

Functional benefit

Products and services

• TirzaTrim Tirzepatide-based multi-dose pre-filled pen for glycemic control in adults and children aged 10+ with type 2 diabetes and for weight management in adults with obesity or overweight with weight-related comorbidities.
• Xelvira Capecitabine 500mg tablets for treatment of multiple solid tumors including colorectal, breast, gastric, esophageal, gastroesophageal junction, and pancreatic cancers.
• Seglu Semaglutide GLP-1 receptor agonist pre-filled syringe for cardiovascular risk reduction, glycemic control, renal protection, weight management, and noncirrhotic MASH treatment.
• Fliximac Infliximab 100mg anti-TNF agent as lyophilized powder for infusion for treatment of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, plaque psoriasis, and ulcerative colitis.
• Dafrova Daprodustat tablets (2mg, 4mg, 6mg) for treatment of anaemia due to chronic kidney disease in adults who have been receiving dialysis for at least four months.
• Adalin Cough syrup (32mg+8mg+30mg+0.98mg per ml) for symptomatic treatment of productive cough, allergic cough, smoker's cough, dry irritating cough, and acute/chronic bronchitis.
• Atizox Nitazoxanide 500mg tablets and 100mg/5ml suspension for treatment of diarrhea due to intestinal parasitic infections (Cryptosporidium parvum and Giardia lamblia).
• Bismol Bismuth-based product (265mg tablets, 88mg/5ml suspension) for upset stomach, indigestion, heartburn, nausea, and diarrhea control.
• Co-Amoxi Amoxicillin + Clavulanic Acid antibiotic in tablets, suspension, BD suspension, injection, and drops for respiratory tract infections, otitis media, sinusitis, skin infections, and UTIs.
• Clavox Amoxicillin antibiotic in 250mg, 500mg, and 1000mg vials for treatment of lower respiratory tract infections, genitourinary infections, gynecologic infections, bacteremia/septicemia, skin infections, and intra-abdominal infections.
• Mclevo Levofloxacin antibiotic in 250mg, 500mg, and 750mg tablets for treatment of bacterial infections including pneumonia, chronic bronchitis, sinusitis, urinary tract infections, and skin infections.
• Ciproquine Ciprofloxacin antibiotic in 250mg, 500mg tablets and 200mg/100ml infusion for urinary tract infections, respiratory infections, skin infections, bone and joint infections, infectious diarrhea, and typhoid fever.
• Itoguard Itopride hydrochloride 50mg tablets and 150mg OD capsules for treatment of gastrointestinal symptoms of functional dyspepsia including bloating, early satiety, upper abdominal pain, anorexia, heartburn, nausea, and vomiting.
• Esante Esomeprazole 20mg and 40mg capsules for treatment of GERD, healing of erosive esophagitis, NSAID-associated gastric ulcer risk reduction, and H. pylori eradication.
• Avelia Tablets Calcium supplement (400 I.U. Vitamin D + 90 mcg Vitamin K + 500 mg calcium) for prevention and treatment of osteoporosis, pregnancy/lactation calcium needs, and bone mineral density improvement.
• Ecavir Entecavir 0.5mg tablets for treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and persistent elevations in serum aminotransferases.
• Epilepsin Carbamazepine 200mg tablets for treatment of partial seizures with complex symptomatology, generalized tonic-clonic seizures, mixed seizure patterns, and trigeminal neuralgia.
• Glio Glimepiride 1mg, 2mg, 3mg, 4mg tablets as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.
• Tacip Piperacillin + Tazobactam 2.25g and 4.5g powder for injection for treatment of intra-abdominal infections, skin infections, urinary tract infections, pneumonia, bacterial septicemia, and bone/joint infections.
• Tio-Veez Tiotropium bromide 18mcg capsules for long-term once-daily maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
• Epuram Amino acid supplement containing L-Arginine + L-Citrulline + L-Ornithine in tablet, injection, and suspension forms for nutritional supplementation.
• Vireof Tenofovir Disoproxil Fumarate 300mg tablets for treatment of chronic hepatitis B in adults and pediatric patients 12+ and HIV-1 infection in combination with other antiretroviral agents.
• Titan Ceftriaxone antibiotic in 250mg, 500mg, 1000mg, 2000mg for treatment of lower respiratory tract infections, otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory diseases, bone/joint infections, and meningitis.
• DX3 Softgel Vitamin D 50,000 I.U. softgel capsules for treatment of refractory rickets, familial hypophosphatemia, hypoparathyroidism, hypocalcemia, renal osteodystrophy, and osteoporosis management.
• Silo Sitagliptin 50mg and 100mg tablets as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus.
• Maxima Cefixime antibiotic in tablets (200mg), capsules (400mg), and dry suspensions for treatment of urinary tract infections, otitis media, pharyngitis, tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea.
• Mactifen Cetirizine 1mg tablets and syrup for symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.
• Contract Manufacturing Services Contract manufacturing services for world-leading healthcare companies in Pakistan; the largest contract manufacturer in Pakistan providing pharmaceutical, biological, and consumer product manufacturing at scale of 1 billion tablets per year.

Quantifiable outcome

• 1 billion tablets manufactured per year
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered support, minor and core.

• F.D. Registrar Services (SMC-Pvt) LtdsupportOthersShare registrar services provider for Macter's stock exchange operations. Located at 17th Floor, Saima Trade Tower A, I.I. Chundrigar Road Karachi.
• Various NGOsminorStrategic or Co-development PartnerMacter has partnered with various NGOs for Hepatitis B vaccination campaigns across Pakistan, including programs from 2002-2008 that reached large populations at 50% cost.
• World Leading Healthcare CompaniescoreChannel Partner/ Reseller/ DistributorMacter serves as the largest contract manufacturer for world leading healthcare companies in Pakistan, providing pharmaceutical manufacturing services.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• OBS Pakistan (Obsons Group): Pakistani pharma group with branded generics and contract manufacturing; competes with Macter in the same domestic therapeutic areas and in international tenders.
• Getz Pharma: Pakistani pharmaceutical manufacturer with branded generics, biologics and contract manufacturing; the most direct local comparable to Macter across therapeutic categories and export footprint.
• The Searle Company: PSX-listed Pakistani pharma with branded generics, manufacturing and 16+ country export operations; competes directly with Macter in cardiology, diabetes, and contract manufacturing.
• Hilton Pharma: Pakistani pharma manufacturer across antibiotics, cardiology and gastroenterology with branded and contract manufacturing - directly overlapping Macter's small-molecule portfolio.
• AGP Limited: Pakistani pharmaceutical manufacturer focused on branded generics and licensed products; competes directly with Macter in therapeutic categories such as cardiology and CNS.
• Ferozsons Laboratories: PSX-listed Pakistani pharmaceutical company with branded generics and strategic manufacturing partnerships (e.g., Gilead HCV licensing); comparable in scale and product mix.
• CCL Pharmaceuticals: Pakistani pharmaceutical manufacturer with branded generics, licensing partnerships and export operations; directly comparable to Macter across manufacturing scale and product portfolio.

Broad incumbents

• Aurobindo Pharma: Largest Indian generic and API manufacturer with a global biosimilar pipeline targeting the same molecules as Macter's launches (infliximab, oncology); broader scale but overlapping therapeutic and export ambitions.
• Cipla: Major Indian pharma with strong presence in Pakistan and emerging markets; comparable therapeutic mix (anti-infectives, respiratory, diabetes) and global export reach overlapping with Macter's 16-country footprint.

Regional players

• Renata Limited: Bangladesh's largest pharmaceutical company (also listed on its domestic exchanges) with branded generics, biologics and animal health; comparable in scale, regulatory strategy and emerging-market export model to Macter.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/289325

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Macter